Dr. Öğr. Üyesi ERTUĞRUL ÇAĞRI BÖLEK

Yayın Ağı

Makaleler 70

1. Ophthalmic involvement in VEXAS syndrome and its influence on mortality: insights from the international AIDA network registry

Sota J., Hinojosa-Azaola A., Martin-Nares E., Sfriso P., Bindoli S., Hissaria P., et al.

FRONTIERS IN IMMUNOLOGY , cilt.17, 2026 (SCI-Expanded, Scopus)

2. Building bridges for early-career rheumatologists in Türkiye: insights from the Turkish Society for Rheumatology—young rheumatologists

BÖLEK E. Ç., Ayan G., BİLGİN E., Ilgen U., Oztas M., Kabasakal Y., et al.

Rheumatology , cilt.65, sa.2, 2026 (SCI-Expanded, Scopus)

3. Lipoid proteinosis mimicking Sjögren’s syndrome: a diagnostic challenge in rheumatology practice

Baltaci M. A., Taşdelen E., Toptas G., Pamukcu M., Kurtulus Ozturk E., Ozmen O., et al.

Rheumatology , cilt.65, sa.2, 2026 (SCI-Expanded, Scopus)

4. Assessment of interstitial lung disease in systemic sclerosis using oscillometric methods: a novel approach to respiratory assessment

Vasi İ., Karaduman İ., Alacaoğlu Ş., Duygulu S., Kardaş R. C., Yıldırım D., et al.

RHEUMATOLOGY , cilt.65, sa.1, 2026 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

5. Venous Thromboembolism May Be Increased in the Early Phases of ANCA-Associated Vasculitis and Could Be Associated With a High Body Mass Index: TR-VaS Experience

Kocaayan H., Ediboglu E. D., Yıldırım T. D., Ulusoy B. O., Ogut T. S., Firlatan B., et al.

International journal of rheumatic diseases , cilt.28, sa.12, 2025 (SCI-Expanded, Scopus)

6. Genetic susceptibility and validation of angiographic patterns in Takayasu arteritis

Casares-Marfil D., Gribbons K. B., Saruhan-Direskeneli G., Kaymaz-Tahra S., Quinn K. A., Alibaz-Oner F., et al.

Journal of Autoimmunity , cilt.157, 2025 (SCI-Expanded, Scopus)

7. Turkish Society for Rheumatology (Turkish Takayasu Arteritis Study Group) recommendations for the diagnosis, follow-up and the treatment of Takayasu's arteritis

ALİBAZ ÖNER F., Kaymaz-Tahra S., Ince B., BÖLEK E. Ç., Yüce Inel T., Öz H. E., et al.

Clinical and experimental rheumatology , cilt.43, sa.11, ss.1928-1944, 2025 (SCI-Expanded, Scopus)

8. Use of JAK inhibitors in patients with refractory Takayasu arteritis: A worldwide retrospective study

ALİBAZ F., ÇAKIR İ. Y., Tomelleri A., Avcu A., Quinn K., Misra D. P., et al.

ARTHRITIS & RHEUMATOLOGY , cilt.77, ss.3169-3171, 2025 (SCI-Expanded, Scopus)

9. Refractory Nodular Scleritis as a Presenting Sign of Colorectal Cancer

Duran R., Kıran Y., Özdemir Yalçınsoy K., Bölek E. Ç., Erden A.

OCULAR IMMUNOLOGY AND INFLAMMATION , cilt.33, sa.7, ss.1479-1482, 2025 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

10. Educational and skill development needs of early-career rheumatologists in Türkiye Türkiye’de çalışmakta olan kariyerinin başındaki romatologların eğitim ve beceri geliştirme ihtiyaçları

Öztaş M., Ayan G., BİLGİN E., BÖLEK E. Ç., İlgen U.

Journal of Turkish Society For Rheumatology , cilt.17, sa.2, ss.102-106, 2025 (Scopus, TRDizin)

11. Comment on: Fibroblast activation protein inhibitor-positron emission tomography in aortitis: fibroblast pathology in active inflammation and remission

Bolek E. Ç., Karadeniz H., TUFAN A.

RHEUMATOLOGY , cilt.64, sa.6, ss.4087-4088, 2025 (SCI-Expanded, Scopus)

12. Is Myopenia or Myosteatosis Clinically Relevant in Systemic Sclerosis? Skeletal Muscle Assessment Using Computed Tomography

Kılıç A. C., Vasi İ., Kılıç H. K., Erden A., Gündoğdu O., Kardaş R. C., et al.

ACADEMIC RADIOLOGY , cilt.32, sa.6, ss.3574-3584, 2025 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

13. DOES CRANIAL GIANT CELL ARTERITIS (GCA) AFFECT BRANCHES OF BOTH EXTERNAL AND INTERNAL CAROTID ARTERIES ATRANSORBITAL DOPPLER ULTRASOUND AND OPTICAL COHERENCE TOMOGRAPHY STUDY

KARADAĞ Ö., Uzun G. S., ESEN Ü., Sadigh S. L., Tahillioglu Y., Tan A. A., et al.

ANNALS OF THE RHEUMATIC DISEASES , cilt.84, ss.429-430, 2025 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

14. MUSCLE MRI IN POLYARTERITIS NODOSA: CONSISTENT FINDINGS IN 6 PATIENTS

KARADAĞ Ö., Yazgan B. F., Ayan G., BÖLEK E. Ç., KALYONCU U., YILDIZ A. N., et al.

ANNALS OF THE RHEUMATIC DISEASES , cilt.84, 2025 (SCI-Expanded, Scopus)

15. WHAT HAS THE FDA'S BLACK BOX WARNINGS FOR JAKi CHANGED IN REAL LIFE HUR-BIO REAL-LIFE EXPERIENCE

Bulat B., Ekici M., Yazgan B. F., Bayram G. S. K., Unaldi E., Ayan G., et al.

ANNALS OF THE RHEUMATIC DISEASES , cilt.84, 2025 (SCI-Expanded, Scopus)

16. BEHCET'S DISEASE BEYOND THE CRITERIA: INSIGHTS FROM ATERTIARY CENTER IN TURKEY

Yazgan B. F., Mavi E. A. S., Bayram G. S. K., Bulat B., Ekici M., Unaldi E., et al.

ANNALS OF THE RHEUMATIC DISEASES , cilt.84, ss.1577, 2025 (SCI-Expanded, Scopus)

17. Systematic literature review and meta-analysis informing the EULAR points to consider on the initiation of targeted therapies in patients with inflammatory arthritis and a history of cancer

Sebbag E., Molina-Collada J., Ndoye R., Aletaha D., Askling J., Gente K., et al.

ANNALS OF THE RHEUMATIC DISEASES , cilt.84, ss.643-652, 2025 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

18. 2024 EULAR points to consider on the initiation of targeted therapies in patients with inflammatory arthritis and a history of cancer

Sebbag E., Lauper K., Molina-Collada J., Aletaha D., Askling J., Gente K., et al.

ANNALS OF THE RHEUMATIC DISEASES , cilt.84, ss.388-397, 2025 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

19. Behçet's disease beyond the criteria: insights from a tertiary centre in Turkey.

Firlatan Yazgan B., Sahin Mavi E. A., Kart Bayram G. S., Bulat B., Ekici M., Unaldi E., et al.

Clinical and experimental rheumatology , cilt.43, ss.1782-1788, 2025 (SCI-Expanded, Scopus)

20. Clinical Characteristics and Outcomes of Polyarteritis Nodosa: An International Study.

Karadag O., Bolek E. Ç., Ayan G., Mohammad A. J., Grayson P. C., Pagnoux C., et al.

Arthritis & rheumatology (Hoboken, N.J.) , cilt.76, sa.7, ss.1120-1129, 2024 (SCI-Expanded, Scopus)

21. Unveiling cancer risk in ANCA-associated vasculitis: result from the Turkish Vasculitis Study Group (TRVaS).

Bilgin E., Demirci Yıldırım T., Özdemir Ulusoy B., Öğüt T. S., Karabacak M., Sadioğlu Çağdaş Ö., et al.

Internal and emergency medicine , cilt.19, sa.4, ss.1025-1034, 2024 (SCI-Expanded, Scopus)

22. EULAR recommendations for the use of imaging in large vessel vasculitis in clinical practice: 2023 update

Dejaco C., Ramiro S., Bond M., Bosch P., Ponte C., Mackie S. L., et al.

ANNALS OF THE RHEUMATIC DISEASES , cilt.83, sa.6, ss.741-751, 2024 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

23. Development of the Takayasu Arteritis Integrated Disease Activity Index

Marvisi C., BÖLEK E. Ç., Ahlman M. A., Alessi H., Redmond C., Muratore F., et al.

ARTHRITIS CARE & RESEARCH , cilt.76, sa.4, ss.531-540, 2024 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

24. Factors that predict development of chronic kidney disease in patients with rheumatoid arthritis receiving biologic DMARDs and mortality rates

Uzun G. S., Taghiyeva A., YALÇIN ÇAKIR F., Moral K., Yardimci G. K., BÖLEK E. Ç., et al.

INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES , cilt.27, sa.1, 2024 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

25. A close look at the nutritional status and mediterranean diet adherence in patients with Behcet's syndrome

ERSOY N., BÖLEK E. Ç., Farisogullari B., Cinar N., Garipoglu G., Colak S., et al.

MEDITERRANEAN JOURNAL OF NUTRITION AND METABOLISM , cilt.17, sa.1, ss.43-52, 2024 (ESCI, Scopus) Sürdürülebilir Kalkınma

26. IgG4-related pachymeningitis-Long term follow up and outcome of six patients

Yardimci G. K., Arslan D., Babaoglu B., BÖLEK E. Ç., KILIÇ L., AYHAN E. A., et al.

INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES , cilt.26, sa.9, ss.1853-1860, 2023 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

27. Comparison of demographic, clinic and radiological features of patients with axial spondyloarthritis accompanying familial Mediterranean fever to patients with each condition alone

Kiraci M., BİLGİN E., Duran E., Farisogullari B., BÖLEK E. Ç., Yardimci G. K., et al.

SCANDINAVIAN JOURNAL OF RHEUMATOLOGY , cilt.52, sa.5, ss.530-538, 2023 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

28. High 30-day readmission rates in hospitalized patients with heart failure: Strengthening the need for a multidisciplinary and integrated approach

Bolek H., cetik s., CEYLAN F., Bolek E. C., Uyaroğlu O. A., Tanriover M. D.

Acta Medica , cilt.54, sa.2, ss.116-126, 2023 (TRDizin)

29. Fertility, early menopause and pregnancy outcomes of patients with Takayasu?s arteritis

Taghiyeva A., KILIÇ L., ÇAĞAN M., BÖLEK E. Ç., Yardimci G. K., Ozyuncu O., et al.

EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY , cilt.283, ss.1-5, 2023 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

30. Drug retention rate and predictive factors of drug survival for secukinumab in radiographic axial spondyloarthritis

Armagan B., KILIÇ L., Farisogullari B., Yardimci G. K., BİLGİN E., BÖLEK E. Ç., et al.

RHEUMATOLOGY INTERNATIONAL , cilt.43, sa.1, ss.147-156, 2023 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

31. Investigation of anterior segment structures of the eye in Behcet's disease using in vivo confocal microscopy

DİKMETAŞ SANDIKÇI Ö., Aygun O., BÖLEK E. Ç., KOCABEYOĞLU S., KARADAĞ Ö., KARAKAYA KARABULUT J., et al.

GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY , cilt.260, sa.12, ss.3897-3902, 2022 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

32. Use of ¹⁸F-fluorodeoxyglucose positron emission tomography to standardize clinical trial recruitment in Takayasu's arteritis

Quinn K. A., Alessi H., Ponte C., Rose E., Ahlman M. A., Redmond C., et al.

RHEUMATOLOGY , cilt.61, sa.10, ss.4047-4055, 2022 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

33. Somatic mutations in rheumatological diseases: VEXAS syndrome and beyond

Sikora K. A., Wells K., BÖLEK E. Ç., Jones A., Grayson P. C.

RHEUMATOLOGY , cilt.61, sa.8, ss.3149-3160, 2022 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

34. Isolated spinal cord granulomatous angiitis: a case report and review of the literature

AYVACIOĞLU ÇAĞAN C., TEMUÇİN Ç. M., Arslan D., GÖÇMEN R., BÖLEK E. Ç., Söylemezoğlu F., et al.

Journal of Neurology , cilt.269, sa.6, ss.3175-3179, 2022 (SCI-Expanded, Scopus)

35. Anxiety levels before biologic initiation and changes with treatment in patients with psoriatic arthritis: HUR-BIO biologic registry results

Ayan G., Farisogullari B., BİLGİN E., BÖLEK E. Ç., KubraYardimci G., Duran E., et al.

CLINICAL RHEUMATOLOGY , cilt.41, sa.5, ss.1439-1446, 2022 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

36. Comprehensive assessment and outcomes of patients with chronic periaortitis

Yardimci G., Düzgün S. A., Farisogullari B., Bolek E. Ç., ELDEM F. G., Erden A., et al.

CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , cilt.40, sa.4, ss.801-810, 2022 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

37. The clinical features and treatment of eosinophilic granulomatosis with polyangiitis (EGPA) in Turkey: one or two distinct diseases?

Duran E., Bostan O. C., BİLGİN E., KAYA S. B., BÖLEK E. Ç., ÖZER S., et al.

INTERNAL AND EMERGENCY MEDICINE , cilt.17, sa.3, ss.743-751, 2022 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

38. A prospective observational cohort study and systematic review of 40 patients with mouth and genital ulcers with inflamed cartilage (MAGIC) syndrome

Luo Y., BÖLEK E. Ç., Quinn K. A., Wells K., Rose E., Sikora K., et al.

Seminars in Arthritis and Rheumatism , cilt.52, 2022 (SCI-Expanded, Scopus)

39. Is the impact of biologic agents in enteropathic spondylitis different from other spondylitis? Real life data from the HUR-BIO Registry

Farisogullari B., Yardimci G. K., Sari A., BİLGİN E., BÖLEK E. Ç., Duran E., et al.

CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , cilt.40, sa.1, ss.112-119, 2022 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

40. Pleuroparenchymal fibroelastosis in systemic sclerosis-associated interstitial lung disease

Sari A., Onder O., Armagan B., BÖLEK E. Ç., Farisogullari B., BİLGİN E., et al.

TURKISH JOURNAL OF MEDICAL SCIENCES , cilt.52, sa.1, ss.83-88, 2022 (SCI-Expanded, Scopus, TRDizin) Sürdürülebilir Kalkınma

41. The influence of obesity on biological agents treatment response in psoriatic arthritis: HUR-BIO real life results Obezitenin psöriyatik artritte biyolojik ajan tedavi yanıtı üzerindeki etkisi: HUR-BIO gerçek yaşam sonuçları

Farisoğulları B., Yardımcı G. K., Sarı A., Armağan B., BİLGİN E., BÖLEK E. Ç., et al.

Journal of Turkish Society For Rheumatology , cilt.13, sa.3, ss.107-115, 2021 (Scopus, TRDizin)

42. In the era of disease-modifying antirheumatic drugs, how close are we to treating rheumatoid arthritis without the use of glucocorticoids?

YAĞIZ B., COŞKUN B. N., PEHLİVAN Y., DALKILIÇ H. E., KİRAZ S., YAZISIZ V., et al.

RHEUMATOLOGY INTERNATIONAL , cilt.41, sa.11, ss.1915-1924, 2021 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

43. Coronary (peri)-arteritis in patients with IgG4-related disease: A case series from the Central Anatolia Region of Turkey

Yardimci G. K., ARDALI DÜZGÜN S., BÖLEK E. Ç., KILIÇ L., CANPOLAT U., HAZIROLAN T., et al.

International Journal of Rheumatic Diseases , cilt.24, sa.8, ss.1004-1013, 2021 (SCI-Expanded, Scopus)

44. Biological and targeted-synthetic disease-modifying antirheumatic drugs with concomitant methotrexate or leflunomide in rheumatoid arthritis: Real-life TReasure prospective data

Kimyon G., KALYONCU U., KİRAZ S., Bes C., COŞKUN N. F., YAĞIZ B., et al.

Clinical and Experimental Rheumatology , cilt.39, sa.4, ss.852-858, 2021 (SCI-Expanded, Scopus)

45. Spinal and cerebral hematoma in systemic lupus erythematosus and antiphospholipid syndrome: Is drug interaction the culprit?

Duran E., BİLGİN E., BÖLEK E. Ç., Flrat O., Bulut E., KALYONCU U., et al.

Drug Metabolism and Personalized Therapy , cilt.36, sa.2, ss.169-172, 2021 (Scopus)

46. A case report of intracranial hypertension and aseptic meningitis: Anti-tumor necrosis factor associated or juvenile idiopathic arthritis related

KAYA AKCA Ü., Sökmen O., BÖLEK E. Ç., DEMİR S., KILIÇ L., Çevik I. Ü., et al.

Turkish Journal of Pediatrics , cilt.63, sa.3, ss.522-526, 2021 (SCI-Expanded, Scopus, TRDizin)

47. COVID-19 Among Patients With Inflammatory Rheumatic Diseases

Esatoglu S. N., Tascilar K., Babaoglu H., Bes C., Yurttas B., AKAR S., et al.

FRONTIERS IN IMMUNOLOGY , cilt.12, 2021 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

48. Direct oral anticoagulant for venous thrombosis in Behçet's syndrome

Vautier M., Gallien Y., Emmi G., Bettiol A., KARADAĞ Ö., BÖLEK E. Ç., et al.

Autoimmunity Reviews , cilt.20, sa.4, 2021 (SCI-Expanded, Scopus)

49. Is Takayasu’s arteritis more severe in children?

BÖLEK E. Ç., KAYA AKCA Ü., Sari A., SAĞ E., DEMİR S., KILIÇ L., et al.

Clinical and Experimental Rheumatology , cilt.39, sa.2, 2021 (SCI-Expanded, Scopus)

50. Iron deficiency and heart failure

Sener Y. Z., Oksul M., BÖLEK E. Ç.

ACTA CARDIOLOGICA , cilt.76, sa.1, ss.107, 2021 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

51. Efficacy, retention, and safety of tofacitinib in real-life: Hur-bio monocentric experience

BİLGİN E., Ceylan F., Duran E., Farisoğullari B., BÖLEK E. Ç., Yardimci G. K., et al.

Turkish Journal of Medical Sciences , cilt.51, sa.1, ss.297-308, 2021 (SCI-Expanded, Scopus, TRDizin)

52. Cerebral vasomotor reactivity in medically stabilized patients with takayasu’s arteritis Takayasu arteritinde stabil hastalık döneminde serebral vazomotor reaktivite

Pektezel M. Y., Rovshanov S., BÖLEK E. Ç., Khasiyev F., KARADAĞ Ö., ARSAVA E. M., et al.

Turk Noroloji Dergisi , cilt.27, sa.2, ss.123-127, 2021 (ESCI, Scopus, TRDizin)

53. Economic Burden of Osteoporotic Fractures: The Tip of the Iceberg?

BÖLEK H., BÖLEK E. Ç., DURUSU TANRIÖVER M.

AMERICAN JOURNAL OF MANAGED CARE , cilt.26, sa.12, 2020 (SCI-Expanded, SSCI, Scopus) Sürdürülebilir Kalkınma

54. Cancer incidence in Behçet’s disease

GÜVEN D. C., BÖLEK E. Ç., Altintop S. E., Celikten B., AKTAŞ B. Y., KİRAZ S., et al.

Irish Journal of Medical Science , cilt.189, sa.4, ss.1209-1214, 2020 (SCI-Expanded, Scopus)

55. Orthostatic hypotension among elderly patients in Italian internal medicine wards: an observational study—comment

Bolek H., BÖLEK E. Ç.

Internal and Emergency Medicine , cilt.15, sa.7, ss.1353-1354, 2020 (SCI-Expanded, Scopus)

56. Some concerns about poor outcome predictors for influenza virus infections

Bolek H., BÖLEK E. Ç.

European Journal of Internal Medicine , cilt.78, ss.139-140, 2020 (SCI-Expanded, Scopus)

57. Predictors of drug retention and treatment response in axial spondyloarthritis patients treated with certolizumab: Real-life results from the HURBIO registry

BİLGİN E., Farisoğulları B., Armağan B., Sarı A., Yardımcı G. K., BÖLEK E. Ç., et al.

Clinical and Experimental Rheumatology , cilt.38, sa.4, ss.609-614, 2020 (SCI-Expanded, Scopus)

58. Management of Behcet's syndrome

KARADAĞ Ö., BÖLEK E. Ç.

Rheumatology (United Kingdom) , cilt.59, 2020 (SCI-Expanded, Scopus)

59. Emergence of colistin and carbapenem-resistant Acinetobacter calcoaceticus-Acinetobacter baumannii (CCR-Acb) complex in a neurological intensive care unit followed by successful control of the outbreak

METAN G., Zarakolu P., OTLU B., Tekin İ., Aytaç H., BÖLEK E. Ç., et al.

Journal of Infection and Public Health , cilt.13, sa.4, ss.564-570, 2020 (SCI-Expanded, Scopus)

60. Clinical features and disease course of neurological involvement in Behcet's disease: HUVAC experience

BÖLEK E. Ç., Sari A., KILIÇ L., KALYONCU U., Kurne A., Oguz K. K., et al.

Multiple Sclerosis and Related Disorders , cilt.38, 2020 (SCI-Expanded, Scopus)

61. Some concerns from Turkey

BİLGİN E., Ozarli I., Klllç L., BÖLEK E. Ç., Yardlmcl G. K., KARADAĞ Ö.

Annals of the Rheumatic Diseases , cilt.79, sa.2, 2020 (SCI-Expanded, Scopus)

62. Indeterminate cell histiocytosis in a patient with systemic lupus erythematosus and antiphospholipid antibody syndrome: an unusual association

AKDOĞAN N., Demircan C., BÖLEK E. Ç., GÖKÖZ Ö., KARADUMAN A. A.

LUPUS , cilt.29, sa.1, ss.74-78, 2020 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

63. The weekend effect in chronic hemodialysis patients, a single center experience

YILDIRIM T., Sener Y. Z., BÖLEK E. Ç., Yilmaz R., ARICI M., ALTUN B., et al.

Iranian Journal of Kidney Diseases , cilt.14, sa.3, ss.219-223, 2020 (SCI-Expanded, Scopus)

64. Do ANCA-associated vasculitides and IgG4-related disease really overlap or not?

Erden A., Bolek E. Ç., Yardimci K. G., KILIÇ L., Bilgen S. A., KARADAĞ Ö.

International Journal of Rheumatic Diseases , cilt.22, sa.10, ss.1926-1932, 2019 (SCI-Expanded, Scopus)

65. Successful Treatment of Amyloid A-Type Amyloidosis Due to Behcet Disease With Tocilizumab

Ilbay A., Erden A., Sari A., Armagan B., Aktas B. Y., Bolek E. Ç., et al.

JCR-JOURNAL OF CLINICAL RHEUMATOLOGY , cilt.25, sa.4, 2019 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

66. Comment on: Intravenous cyclophosphamide vs rituximab for the treatment of early diffuse scleroderma lung disease: open label, randomized, controlled trial

Oral F., BİLGİN E., BÖLEK E. Ç., Yardimci G. K., KILIÇ L.

RHEUMATOLOGY , cilt.58, sa.5, ss.925, 2019 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

67. Interferon alpha might be an alternative therapeutic choice for refractory Neuro-Behcet's disease

BÖLEK E. Ç., Sari A., KILIÇ L., KARADAĞ Ö.

MULTIPLE SCLEROSIS AND RELATED DISORDERS , cilt.29, ss.153, 2019 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

68. Thrombosis and Bleeding in Philadelphia Negative Myeloproliferative Neoplasia: Incidences and Risk Factors

OKAY M., MALKAN Ü. Y., Bolek E. C., Sayınalp N., BÜYÜKAŞIK Y., Haznedaroglu I. C.

Acta Medica , cilt.50, sa.2, ss.1-7, 2019 (TRDizin)

69. Rare occupational cause of nasal septum perforation: Nickel exposure

Bolek E. Ç., Erden A., Kulekci C., KALYONCU U., KARADAĞ Ö.

International journal of occupational medicine and environmental health , cilt.30, sa.6, ss.963-967, 2017 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

70. The clinical features and outcomes of Turkish patients with IgG4-related disease: A single-center experience

KARADAĞ Ö., Erden A., AYHAN E. A., Bölek E. Ç., KALYONCU U., Armağan B., et al.

Turkish Journal of Medical Sciences , cilt.47, sa.5, ss.1307-1314, 2017 (SCI-Expanded, Scopus, TRDizin)

Hakemli Bilimsel Toplantılarda Yayımlanmış Bildiriler 82

1. POS1213 WHAT HAS THE FDAS BLACK BOX WARNINGS FOR JAKi CHANGED IN REAL LIFE HÜR-BIO REAL-LIFE EXPERIENCE

Bulat B., EKİCİ M., FIRLATAN B., Kart Bayram G. S., ÜNALDI E., AYAN G., et al.

European Congress of Rheumatology-EULAR 2025, Barselona, İspanya, 11 Haziran 2025, cilt.84, ss.1276, (Özet Bildiri)

2. ABS1074 BEHÇETS DISEASE BEYOND THE CRITERIA: INSIGHTS FROM A TERTIARY CENTER IN TURKEY

FIRLATAN B., Şahin Mavi E. A., Kart Bayram G. S., Bulat B., EKİCİ M., ÜNALDI E., et al.

European Congress of Rheumatology-EULAR 2025, Barselona, İspanya, 11 - 14 Haziran 2025, cilt.84, ss.1577, (Özet Bildiri)

3. REMARKING THE OSTEOPOROSIS IN PATIENTS WITH ANCA-ASSOCIATED VASCULITIS (AAV): DATA FROM EASTERN MEDITERRANEAN (TRVAS)

Demirci Yıldırım T., ERPEK KARAOVA E., ÖZDEMİR ULUSOY B., ÜNALDI E., SADİOĞLU ÇAĞDAŞ Ö., KARDAŞ R. C., et al.

European Congress of Rheumatology, Vienna, Avusturya, 12 - 15 Haziran 2024, cilt.83, (Özet Bildiri) Sürdürülebilir Kalkınma

4. VENOUS THROMBOEMBOLISM IN ANCA-ASSOCIATED VASCULITIS MIGHT BE ASSOCIATED WITH DISEASE ACTIVITY: RESULTS OFTR-VaS COHORT

KOCAAYAN H., Durak Ediboğlu E., Demirci Yıldırım T., ÖZDEMİR B., Öğüt T. S., FIRLATAN B., et al.

Meeting of the European-Alliance-of-Associations-for-Rheumatology (EULAR), Vienna, Avusturya, 12 - 15 Haziran 2024, cilt.83, (Özet Bildiri) Sürdürülebilir Kalkınma

5. REAL-LIFE DATA COMPARING THE LONG-TERM OUTCOME AND TREATMENT IN ADULT AND PEDIATRIC DADA2 PATIENTS: SINGLE CENTER EXPERIENCE OVER 10 YEARS

Ayan G., BAŞARAN H. Ö., BÖLEK E. Ç., Firlatan B., Bulat B., BATU AKAL E. D., et al.

Meeting of the European-Alliance-of-Associations-for-Rheumatology (EULAR), Vienna, Avusturya, 12 - 15 Haziran 2024, cilt.83, ss.1113-1114, (Özet Bildiri)

6. ANCA ilişkili vaskülit hastalarında osteoporozu ne kadar tanıyoruz? Çok merkezli retrospektif analiz

DEMİRCİ YILDIRIM T., DURAN E., SADİOĞLU ÇAĞDAŞ Ö., KARDAŞ R. C., KIZILTEPE M., EKİCİ M., et al.

Ulusal Romatoloji Kongresi, Antalya, Türkiye, 11 Ekim 2023, (Tam Metin Bildiri)

7. IgG4-Related Pachymeningitis: How Do I Recognize?

Arslan D., Yardimci G., BABAOĞLU B., BÖLEK E. Ç., KILIÇ L., Saglam A., et al.

9th Joint ECTRIMS-ACTRIMS meeting, Milan, İtalya, 11 - 13 Ekim 2023, cilt.29, ss.656, (Özet Bildiri)

8. PERFORMANCE OF 2022 ACR/EULAR GPA, EGPA AND MPA CLASSIFICATION CRITERIA IN TURKISH VASCULITIS STUDY GROUP PROSPECTIVE COHORT (TRVAS)

BÖLEK E. Ç., AYAN G., BİLGİN E., KÜÇÜK H., ERDEN A., ALİBAZ ÖNER F., et al.

EULAR (Avrupa Romatoloji Kongresi), Milan, İtalya, 31 Mayıs 2023, (Tam Metin Bildiri)

9. DEVELOPMENT OF THE TAKAYASU'S ARTERITIS INTEGRATED DISEASE ACTIVITY INDEX

Marvisi C., BÖLEK E. Ç., Ahlman M., Alessi H., Galli E., Ricordi C., et al.

European Congress of Rheumatology (EULAR), Milan, İtalya, 31 Mayıs - 03 Haziran 2023, cilt.82, ss.641-642, (Özet Bildiri)

10. PERFORMANCE OF 2022 ACR/EULAR GPA, EGPA AND MPA CLASSIFICATION CRITERIA IN TURKISH VASCULITIS STUDY GROUP PROSPECTIVE COHORT (TRVAS)

BÖLEK E. Ç., Ayan G., BİLGİN E., Ediboglu E. D., Duran E., Kardas C., et al.

European Congress of Rheumatology (EULAR), Milan, İtalya, 31 Mayıs - 03 Haziran 2023, cilt.82, ss.1597-1598, (Özet Bildiri) Sürdürülebilir Kalkınma

11. EULAR POINTS TO CONSIDER ON THE INITIATION OF TARGETED THERAPIES IN PATIENTS WITH INFLAMMATORY ARTHRITIDES AND A HISTORY OF CANCER

Sebbag E., Lauper K., Collada J. M., Aletaha D., Askling J., Benesova K., et al.

European Congress of Rheumatology (EULAR), Milan, İtalya, 31 Mayıs - 03 Haziran 2023, cilt.82, ss.29, (Özet Bildiri) Sürdürülebilir Kalkınma

12. AWARENESS OF EDUCATIONAL AND RESEARCH OFFERINGS OF EULAR AND EMEUNET AMONG YOUNG RHEUMATOLOGISTS WORKING IN TURKEY

Oztas M., Ayan G., BİLGİN E., BÖLEK E. Ç., Ilgen U.

European Congress of Rheumatology (EULAR), Milan, İtalya, 31 Mayıs - 03 Haziran 2023, cilt.82, ss.2091-2092, (Özet Bildiri)

13. SYSTEMATIC LITERATURE REVIEW INFORMING THE EULAR POINTS TO CONSIDER TASK FORCE ON THE INITIATION OF TARGETED THERAPIES IN PATIENTS WITH INFLAMMATORY ARTHRITIDES AND A HISTORY OF CANCER

Sebbag E., Molina Collada J., Lauper K., Aletaha D., Askling J., Benesova K., et al.

European Congress of Rheumatology (EULAR), Milan, İtalya, 31 Mayıs - 03 Haziran 2023, cilt.82, ss.856, (Özet Bildiri) Sürdürülebilir Kalkınma

14. EULAR RECOMMENDATIONS FOR THE USE OF IMAGING IN LARGE VESSEL VASCULITIS IN CLINICAL PRACTICE: 2023 UPDATE

Dejaco C., Ramiro S., Bond M., Bosch P., Ponte C., Mackie S., et al.

European Congress of Rheumatology (EULAR), Milan, İtalya, 31 Mayıs - 03 Haziran 2023, cilt.82, ss.205, (Özet Bildiri) Sürdürülebilir Kalkınma

15. HEMATOLOGICAL MALIGNANCIES AND ANTI-TNF IN INFLAMMATORY ARTHRITIS: THE REAL LIFE DATA FROM THE HUR-BIO REGISTRY

Duran E., Ozturk Z. O., BİLGİN E., BÖLEK E. Ç., Yardimci G. K., Farisogullari B., et al.

Annual European Congress of Rheumatology (EULAR), Copenhagen, Danimarka, 1 - 04 Haziran 2022, cilt.81, ss.1064, (Özet Bildiri)

16. THE EMERGING EULAR NETWORK (EMEUNET) PEER-REVIEW MENTORING PROGRAM: TEN YEARS OF INITIATIVE.

Verhoef L. M., Vivekanantham A., Berti A., BÖLEK E. Ç., Smeele H. T., Oztas M., et al.

Annual European Congress of Rheumatology (EULAR), Copenhagen, Danimarka, 1 - 04 Haziran 2022, cilt.81, ss.202-203, (Özet Bildiri) Sürdürülebilir Kalkınma

17. FREQUENCY OF DYSLIPIDEMIA AND COMPLIANCE WITH THE TREATMENT IN PSA PATIENTS USING BDMARDS

Gezerer N. E., Ayan G., BİLGİN E., Yardimci G. K., BÖLEK E. Ç., Farisogullari B., et al.

Annual European Congress of Rheumatology (EULAR), Copenhagen, Danimarka, 1 - 04 Haziran 2022, cilt.81, ss.869, (Özet Bildiri)

18. IS PSORIATIC ARTHRITIS REALLY SERONEGATIVE?

Ayan G., Gezerer N. E., BİLGİN E., Yardimci G. K., BÖLEK E. Ç., Farisogullari B., et al.

Annual European Congress of Rheumatology (EULAR), Copenhagen, Danimarka, 1 - 04 Haziran 2022, cilt.81, ss.1598-1599, (Özet Bildiri) Sürdürülebilir Kalkınma

19. PREDICTORS OF SUSTAINED REMISSION IN PEOPLE WITH AXIAL SPONDYLOARTHRITIS TREATED WITH BIOLOGIC DRUGS

Farisogullari B., Yardimci G. K., BİLGİN E., BÖLEK E. Ç., Duran E., Ayan G., et al.

Annual European Congress of Rheumatology (EULAR), Copenhagen, Danimarka, 1 - 04 Haziran 2022, cilt.81, ss.776, (Özet Bildiri)

20. PREDICTORS OF DEVELOPMENT OF ADVANCED SPINAL ANKYLOSIS/BAMBOO SPINE IN AXIAL SPONDYLOARTHRITIS: RESULTS FROM REAL-LIFE DATA

Farisogullari B., Yardimci G. K., BİLGİN E., BÖLEK E. Ç., Duran E., Ayan G., et al.

Annual European Congress of Rheumatology (EULAR), Copenhagen, Danimarka, 1 - 04 Haziran 2022, cilt.81, ss.803-804, (Özet Bildiri) Sürdürülebilir Kalkınma

21. CARDIOVASCULAR EVENT, VENOUS THROMBOEMBOLIZM, AND INFECTION RISK WITH TOFACITINIB IN RHEUMATOID ARTHRITIS PATIENTS AGED ≥ 60 YEARS

Duran E., Unaldi E., BİLGİN E., BÖLEK E. Ç., Yardimci G. K., Farisogullari B., et al.

Annual European Congress of Rheumatology (EULAR), Copenhagen, Danimarka, 1 - 04 Haziran 2022, cilt.81, ss.1336, (Özet Bildiri) Sürdürülebilir Kalkınma

22. BDMARD CHOICES FOR INFLAMMATORY ARTHRITIS WITH CHRONIC KIDNEY DISEASE; HUR-BIO REAL-LIFE REGISTRY

Uzun G. S., Taghiyeva A., YALÇIN ÇAKIR F., Moral K., BİLGİN E., Yardimci G. K., et al.

Annual European Congress of Rheumatology (EULAR), Copenhagen, Danimarka, 1 - 04 Haziran 2022, cilt.81, ss.1303, (Özet Bildiri) Sürdürülebilir Kalkınma

23. THE FREQUENCY, PREVALENCE OF CORONARY ARTERY DISEASE AND PRE-MATURE CAD IN PSA AND RA PATIENTS

Ayan G., Uzun G. S., Tatar O. D., Gezerer N. E., BİLGİN E., Yardimci G. K., et al.

Annual European Congress of Rheumatology (EULAR), Copenhagen, Danimarka, 1 - 04 Haziran 2022, cilt.81, ss.1263-1264, (Özet Bildiri) Sürdürülebilir Kalkınma

24. DYSLIPIDEMIA TREATMENT IN RHEUMATOID ARTHRITIS PATIENTS USING BDMARDS IS BETTER THAN PSA, BUT THERE IS STILL A WAY TO GO

Uzun G. S., Tatar O. D., Gezerer N. E., BİLGİN E., Yardimci G. K., BÖLEK E. Ç., et al.

Annual European Congress of Rheumatology (EULAR), Copenhagen, Danimarka, 1 - 04 Haziran 2022, cilt.81, ss.1264-1265, (Özet Bildiri)

25. ASSOCIATION OF DEMOGRAPHIC AND CLINICAL CHARACTERISTICS OF PATIENTS WITH FAMILIAL MEDITERRANEAN FEVER AND AXIAL SPONDYLOARTHRITIS WITH THE M694V MUTATION

Kiraci M., BİLGİN E., Duran E., Farisogullari B., BÖLEK E. Ç., Yardimci G. K., et al.

Annual European Congress of Rheumatology (EULAR), Copenhagen, Danimarka, 1 - 04 Haziran 2022, cilt.81, ss.797, (Özet Bildiri) Sürdürülebilir Kalkınma

26. OSTEOPOROSIS IN PATIENTS WITH SPONDYLOARTHRITIS: DO WE NEED TO DO MORE?

Ozsoy Z., Moral K., YEŞİL F., BİLGİN E., BÖLEK E. Ç., Yardimci G. K., et al.

Annual European Congress of Rheumatology (EULAR), Copenhagen, Danimarka, 1 - 04 Haziran 2022, cilt.81, ss.1547, (Özet Bildiri)

27. IN RHEUMATOID ARTHRITIS PATIENTS RECEIVING BDMARDS, THE CHARLSON COMORBIDITY INDEX IS MORE PRONOUNCED THAN PSORIATIC ARTHRITIS

Uzun G. S., Tatar O. D., Gezerer N. E., BİLGİN E., Yardimci G. K., BÖLEK E. Ç., et al.

Annual European Congress of Rheumatology (EULAR), Copenhagen, Danimarka, 1 - 04 Haziran 2022, cilt.81, ss.1265, (Özet Bildiri)

28. THE RELATIONSHIP BETWEEN CHANGES IN PSORIATIC ARTHRITIS DISEASE ACTIVITY AND COMORBIDITIES IN PATIENTS TREATED WITH BDMARDS

Ayan G., Gezerer N. E., BİLGİN E., Yardimci G. K., BÖLEK E. Ç., Farisogullari B., et al.

Annual European Congress of Rheumatology (EULAR), Copenhagen, Danimarka, 1 - 04 Haziran 2022, cilt.81, ss.870, (Özet Bildiri) Sürdürülebilir Kalkınma

29. A Prospective Observational Cohort Study and Systematic Review of 40 Patients with Mouth and Genital Ulcers with Inflamed Cartilage (MAGIC) Syndrome

Luo Y., BÖLEK E. Ç., Quinn K., Wells K., Rose E., Rominger E., et al.

ACR Convergence Conference, ELECTR NETWORK, 5 - 09 Kasım 2021, cilt.73, ss.3921-3922, (Özet Bildiri)

30. ¹⁸F-Fluorodeoxyglucose PET/MRI as an Alternative Hybrid Imaging Modality: Comparative Study in a Prospective, Longitudinal Cohort of Patients with Large-Vessel Vasculitis

BÖLEK E. Ç., Quinn K., Alessi H., Novakovich E., Ahlman M. A., Grayson P.

ACR Convergence Conference, ELECTR NETWORK, 5 - 09 Kasım 2021, cilt.73, ss.3898-3900, (Özet Bildiri)

31. Real-life Data for the Use of Anti-TNF Treatment in DADA2

KARADAĞ Ö., Ayan G., BAŞARAN H. Ö., BÖLEK E. Ç., KILIÇ L., BİLGİNER Y., et al.

ACR Convergence Conference, ELECTR NETWORK, 5 - 09 Kasım 2021, cilt.73, ss.3935-3939, (Özet Bildiri)

32. Using 18F-fluorodeoxyglucose Positron Emission Tomography to Standardize Clinical Trial Recruitment in Takayasu's Arteritis

Quinn K., Alessi H., Rose E., Ahlman M. A., Redmond C., Luo Y., et al.

ACR Convergence Conference, ELECTR NETWORK, 5 - 09 Kasım 2021, cilt.73, ss.3918-3919, (Özet Bildiri)

33. Comparison of Demographic, Clinic and Radiological Features of Axial Spondyloarthritis Patients with and Without Accompanying Familial Mediterranean Fever

Kiraci M., BİLGİN E., Duran E., Farisogullari B., BÖLEK E. Ç., Yardimci G. K., et al.

ACR Convergence Conference, ELECTR NETWORK, 5 - 09 Kasım 2021, cilt.73, ss.771-773, (Özet Bildiri)

34. Cancer in Patients with ANCA-associated Vasculitis: Which Came First, the Chicken or the Egg?

Ediboglu E., Kardas R. C., BÖLEK E. Ç., Yildirim R., Guven D., Kilickap S., et al.

ACR Convergence Conference, ELECTR NETWORK, 5 - 09 Kasım 2021, cilt.73, ss.867-870, (Özet Bildiri)

35. Validation of Angiographic Patterns of Disease in a Turkish Cohort of Patients with Takayasu's Arteritis

Gribbons K. B., Kaymaz--Tahra S., ALİBAZ F., BÖLEK E. Ç., KARADAĞ Ö., İNCE B., et al.

ACR Convergence Conference, ELECTR NETWORK, 5 - 09 Kasım 2021, cilt.73, ss.3941-3943, (Özet Bildiri)

36. RENAL BIOPSY IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS: IS IT ONLY LUPUS NEPHRITIS?

Duran E., YILDIRIM T., KALYONCU U., Taghiyeva A., BİLGİN E., Saglam E. A., et al.

Annual European Congress of Rheumatology (EULAR), ELECTR NETWORK, 2 - 05 Haziran 2021, cilt.80, ss.1198-1199, (Özet Bildiri) Sürdürülebilir Kalkınma

37. FERTILITY AND PREGNANCY OUTCOMES IN TAKAYASU'S ARTERITIS

Taghiyeva A., KILIÇ L., ÇAĞAN M., BÖLEK E. Ç., Yardimci G. K., KARADAĞ Ö., et al.

Annual European Congress of Rheumatology (EULAR), ELECTR NETWORK, 2 - 05 Haziran 2021, cilt.80, ss.659-660, (Özet Bildiri)

38. ANXIETY IN PSORIATIC ARTHRITIS PATIENTS: RESULTS FROM THE HUR-BIO BIOLOGIC REGISTRY

Ayan G., Farisogullari B., BİLGİN E., BÖLEK E. Ç., Yardimci G. K., Duran E., et al.

Annual European Congress of Rheumatology (EULAR), ELECTR NETWORK, 2 - 05 Haziran 2021, cilt.80, ss.814, (Özet Bildiri) Sürdürülebilir Kalkınma

39. TRENDS IN THE CHOICE OF FIRST BIOLOGIC AND TARGETED SYNTHETIC DMARD IN RHEUMATOID ARTHRITIS PATIENTS: 20-YEARS JOURNEY OF HURBIO REAL-LIFE REGISTRY

ERTENLİ A. İ., KALYONCU U., KARADAĞ Ö., KILIÇ L., AKDOĞAN A., Dogan I., et al.

Annual European Congress of Rheumatology (EULAR), ELECTR NETWORK, 2 - 05 Haziran 2021, cilt.80, ss.1124, (Özet Bildiri) Sürdürülebilir Kalkınma

40. CHANGES IN THE PRESCRIPTION PATTERNS OF THE SECOND-LINE BIOLOGIC AND TARGETED SYNTHETIC DMARD IN RHEUMATOID ARTHRITIS PATIENTS: 20-YEARS JOURNEY OF HUR-BIO REAL-LIFE REGISTRY

KİRAZ S., KALYONCU U., KARADAĞ Ö., KILIÇ L., AKDOĞAN A., Dogan I., et al.

Annual European Congress of Rheumatology (EULAR), ELECTR NETWORK, 2 - 05 Haziran 2021, cilt.80, ss.1124-1125, (Özet Bildiri)

41. PREDICTORS OF END STAGE RENAL DISEASE IN THE RENAL BIOPSY PROVEN LUPUS NEPHRITIS

Duran E., YILDIRIM T., KALYONCU U., Taghiyeva A., AYHAN E. A., ÜNER M., et al.

Annual European Congress of Rheumatology (EULAR), ELECTR NETWORK, 2 - 05 Haziran 2021, cilt.80, ss.648-649, (Özet Bildiri)

42. OBESITY RATES AND BMI ARE SIMILAR IN AGE AND SEX MATCHED RHEUMATOID ARTHRITIS, PSORIATIC ARTHRITIS AND SPONDYLOARTHRITIS PATIENTS

Yardimci G. K., Farisogullari B., BÖLEK E. Ç., BİLGİN E., Duran E., Ayan G., et al.

Annual European Congress of Rheumatology (EULAR), ELECTR NETWORK, 2 - 05 Haziran 2021, cilt.80, ss.518-519, (Özet Bildiri) Sürdürülebilir Kalkınma

43. PRESCRIPTION PATTERNS OF THE SECOND BIOLOGIC DMARD IN PSORIATIC ARTHRITIS THROUGH THE LAST DECADE: HURBIO-PsA REAL LIFE EXPERIENCE

KALYONCU U., KARADAĞ Ö., KILIÇ L., AKDOĞAN A., Dogan I., Bilgen S. A., et al.

Annual European Congress of Rheumatology (EULAR), ELECTR NETWORK, 2 - 05 Haziran 2021, cilt.80, ss.1299, (Özet Bildiri)

44. COMPARISON OF DEMOGRAPHIC AND CLINICAL FEATURES OF FAMILIAL MEDITERRANEAN FEVER PATIENTS AND PATIENTS WITH AXIAL SPONDYLOARTHRITIS ACCOMPANYING FAMILIAL MEDITERRANEAN FEVER

Kiraci M., BİLGİN E., Duran E., Farisogullari B., BÖLEK E. Ç., Yardimci G. K., et al.

Annual European Congress of Rheumatology (EULAR), ELECTR NETWORK, 2 - 05 Haziran 2021, cilt.80, ss.971, (Özet Bildiri)

45. RETENTION RATE AND TREATMENT RESPONSE OF BIOLOGICAL AGENTS IN ADVANCED SPINAL ANKYLOSIS AND BAMBOO SPINE: THE REAL LIFE DATA FROM THE HURBIO REGISTRY

Farisogullari B., Yardimci G. K., BÖLEK E. Ç., BİLGİN E., Duran E., Ayan G., et al.

Annual European Congress of Rheumatology (EULAR), ELECTR NETWORK, 2 - 05 Haziran 2021, cilt.80, ss.728-729, (Özet Bildiri) Sürdürülebilir Kalkınma

46. DURATION OF STARTING bDMARDs ARE ALMOST 3 TIMES LONGER IN RA PATIENTS THAN PsA PATIENTS: HUR-BIO REAL LIFE RESULTS

Yardimci G. K., Farisogullari B., BÖLEK E. Ç., BİLGİN E., Duran E., Ayan G., et al.

Annual European Congress of Rheumatology (EULAR), ELECTR NETWORK, 2 - 05 Haziran 2021, cilt.80, ss.554-555, (Özet Bildiri) Sürdürülebilir Kalkınma

47. BOTH SPONDYLOARTHRITIS AND PSORIATIC ARTHRITIS PATIENTS HAVE STRONG FAMILY HISTORIES

Yardimci G. K., Farisogullari B., BÖLEK E. Ç., BİLGİN E., Duran E., Ayan G., et al.

Annual European Congress of Rheumatology (EULAR), ELECTR NETWORK, 2 - 05 Haziran 2021, cilt.80, ss.770-771, (Özet Bildiri) Sürdürülebilir Kalkınma

48. CONVENTIONAL SYNTHETIC DMARDS IN PSORIATIC ARTHRITIS - CHANGING PRACTICE IN BIOLOGIC ERA: REAL-LIFE RESULTS FROM HURBIO-PSA REGISTRY

BİLGİN E., Duran E., BÖLEK E. Ç., Farisogullari B., Yardimci G. K., KILIÇ L., et al.

Annual European Congress of Rheumatology (EULAR), ELECTR NETWORK, 03 Haziran 2020, cilt.79, ss.1663, (Özet Bildiri)

49. REAL-LIFE EXPERIENCE FOR SECUKINUMAB IN PSORIATIC ARTHRITIS FROM HURBIO-PSA DATABASE

BÖLEK E. Ç., BİLGİN E., Yardimci G. K., Farisogullari B., Duran E., Armagan B., et al.

Annual European Congress of Rheumatology (EULAR), ELECTR NETWORK, 03 Haziran 2020, cilt.79, ss.1665-1666, (Özet Bildiri)

50. THE INFLUENCE OF OBESITY ON BIOLOGICAL DMARD TREATMENT RESPONSE IN PSORIATIC ARTHRITIS: HUR-BIO REAL LIFE RESULTS

Farisogullari B., Yardimci G. K., BÖLEK E. Ç., BİLGİN E., Duran E., Ayan G., et al.

Annual European Congress of Rheumatology (EULAR), ELECTR NETWORK, 03 Haziran 2020, cilt.79, ss.1675-1676, (Özet Bildiri) Sürdürülebilir Kalkınma

51. FACTORS RELATED TO RADIOGRAPHIC PROGRESSION IN PATIENTS WITH RHEUMATOID ARTHRITIS-RELATED INTERSTITIAL LUNG DISEASE

KALYONCU U., Ekici M., BİLGİN E., Sari A., Baytar Y., BÖLEK E. Ç., et al.

Annual European Congress of Rheumatology (EULAR), ELECTR NETWORK, 03 Haziran 2020, cilt.79, ss.1394, (Özet Bildiri) Sürdürülebilir Kalkınma

52. CONCOMITANT PSORIATIC ARTHRITIS AND INFLAMMATORY BOWEL DISEASE IN THE PSA BIOLOGICAL REGISTRY: HUR-BIO REAL LIFE RESULTS

Yardimci G. K., Farisogullari B., Armagan B., BİLGİN E., BÖLEK E. Ç., Duran E., et al.

Annual European Congress of Rheumatology (EULAR), ELECTR NETWORK, 03 Haziran 2020, cilt.79, ss.1174-1175, (Özet Bildiri)

53. INCIDENCE RATE OF HERPES ZOSTER IN RHEUMATOID ARTHRITIS PATIENTS UNDER TOFACITINIB: REAL-LIFE DATA FROM TURKEY - HURBIO REGISTRY

BİLGİN E., Ceylan F., Duran E., BÖLEK E. Ç., Farisogullari B., Yardimci G. K., et al.

Annual European Congress of Rheumatology (EULAR), ELECTR NETWORK, 03 Haziran 2020, cilt.79, ss.636, (Özet Bildiri) Sürdürülebilir Kalkınma

54. CANCER INCIDENCE AND FEATURES IN ADULT VASCULITIS PATIENTS

Kardas R. C., BÖLEK E. Ç., AKTAŞ B. Y., Kilickap S., KARADAĞ Ö.

Annual European Congress of Rheumatology (EULAR), ELECTR NETWORK, 03 Haziran 2020, cilt.79, ss.682-683, (Özet Bildiri) Sürdürülebilir Kalkınma

55. SUBPHENOTYPES IN POLYARTERITIS NODOSA (PAN): TARGET ORGAN ASSOCIATIONS OF A WORLDWIDE COLLABORATION STUDY

KARADAĞ Ö., BÖLEK E. Ç., Furuta S., Emmi G., Hocevar A., Hinojosa-Azaola A., et al.

Annual European Congress of Rheumatology (EULAR), ELECTR NETWORK, 03 Haziran 2020, cilt.79, ss.1060-1061, (Özet Bildiri)

56. LOCALISATION OF RHEUMATOID LUNG NODULES IN PATIENTS WITH RHEUMATOID ARTHRITIS-RELATED INTERSTITIAL LUNG DISEASE: RIGHT OR LEFT?

BİLGİN E., Ekici M., Baytar Y., Duran E., DURHAN G., BÖLEK E. Ç., et al.

Annual European Congress of Rheumatology (EULAR), ELECTR NETWORK, 03 Haziran 2020, cilt.79, ss.277, (Özet Bildiri) Sürdürülebilir Kalkınma

57. CONCOMITANT USE OF BIOLOGIC DMARDS WITH CSDMARDS INCREASES DRUG RETENTION RATE AND IMPROVES TREATMENT RESPONSE IN THE PSORIATIC ARTHRITIS. HUR-BIO REAL LIFE RESULTS

Duran E., BİLGİN E., BÖLEK E. Ç., Yardimci G. K., Farisogullari B., KILIÇ L., et al.

Annual European Congress of Rheumatology (EULAR), ELECTR NETWORK, 03 Haziran 2020, cilt.79, ss.757, (Özet Bildiri)

58. INFLAMMATORY ORBITAL DISEASES: THE EXPERIENCE OF A TERTIARY RHEUMATOLOGY CENTRE

Aksun M. S., Sahin T. K., BÖLEK E. Ç., KILIÇ L., BULUT E. G., Oguz K. K., et al.

Annual European Congress of Rheumatology (EULAR), ELECTR NETWORK, 03 Haziran 2020, cilt.79, ss.1806-1807, (Özet Bildiri)

59. SECUKINUMAB IS FREQUENTLY PREFERRED IN MULTI ANTI-TNF RESISTANCE SPONDYLOARTHRITIS PATIENTS: HUR-BIO REAL LIFE RESULTS

Armagan B., KILIÇ L., Yardimci G. K., BİLGİN E., Farisogullari B., BÖLEK E. Ç., et al.

Annual European Congress of Rheumatology (EULAR), ELECTR NETWORK, 03 Haziran 2020, cilt.79, ss.419-420, (Özet Bildiri)

60. EFFICACY, RETENTION RATE AND PREDICTORS OF TOFACITINIB EFFICACY AND RETENTION IN RHEUMATOID ARTHRITIS PATIENTS: HUR-BIO REAL-LIFE EXPERIENCE

BİLGİN E., Ceylan F., BÖLEK E. Ç., Duran E., Farisogullari B., Yardimci G. K., et al.

Annual European Congress of Rheumatology (EULAR), ELECTR NETWORK, 03 Haziran 2020, cilt.79, ss.1460, (Özet Bildiri)

61. Cancer incidence in Behcet's Disease.

Guven D. C., BÖLEK E. Ç., Altintop S. E., Celikten B., Aktas B. Y., Kiraz S., et al.

Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), ELECTR NETWORK, 29 - 31 Mayıs 2020, cilt.38, (Özet Bildiri)